|
ASX - By Stock
|
PUR |
Re:
Ann: Sascha Marcelina Project Update
|
|
csrwin
|
55 |
18K |
0 |
13/04/26 |
| 13/04/26 |
ASX - By Stock
|
55
|
18K
|
0
|
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Sascha Marcelina Project Update
|
|
csrwin
|
55 |
18K |
1 |
13/04/26 |
| 13/04/26 |
ASX - By Stock
|
55
|
18K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
csrwin
|
288 |
85K |
2 |
08/04/26 |
| 08/04/26 |
ASX - By Stock
|
288
|
85K
|
2
|
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Sascha Marcelina Project Update
|
|
csrwin
|
55 |
18K |
2 |
08/04/26 |
| 08/04/26 |
ASX - By Stock
|
55
|
18K
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
21K |
7.7M |
3 |
03/03/26 |
| 03/03/26 |
ASX - By Stock
|
21K
|
7.7M
|
3
|
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Sascha Marcelina Project Update
|
|
csrwin
|
55 |
18K |
1 |
15/02/26 |
| 15/02/26 |
ASX - By Stock
|
55
|
18K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
21K |
7.7M |
4 |
06/02/26 |
| 06/02/26 |
ASX - By Stock
|
21K
|
7.7M
|
4
|
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Pause in Trading
|
|
csrwin
|
37 |
7.9K |
2 |
30/01/26 |
| 30/01/26 |
ASX - By Stock
|
37
|
7.9K
|
2
|
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Pause in Trading
|
|
csrwin
|
37 |
7.9K |
0 |
30/01/26 |
| 30/01/26 |
ASX - By Stock
|
37
|
7.9K
|
0
|
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Pause in Trading
|
|
csrwin
|
37 |
7.9K |
0 |
29/01/26 |
| 29/01/26 |
ASX - By Stock
|
37
|
7.9K
|
0
|
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Suspension from Quotation
|
|
csrwin
|
1 |
576 |
0 |
29/01/26 |
| 29/01/26 |
ASX - By Stock
|
1
|
576
|
0
|
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Pause in Trading
|
|
csrwin
|
37 |
7.9K |
0 |
29/01/26 |
| 29/01/26 |
ASX - By Stock
|
37
|
7.9K
|
0
|
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Pause in Trading
|
|
csrwin
|
37 |
7.9K |
0 |
27/01/26 |
| 27/01/26 |
ASX - By Stock
|
37
|
7.9K
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
$3 Party
|
|
csrwin
|
283 |
107K |
4 |
22/12/25 |
| 22/12/25 |
ASX - By Stock
|
283
|
107K
|
4
|
|
|
ASX - By Stock
|
MSB |
Re:
$3 Party
|
|
csrwin
|
283 |
107K |
1 |
22/12/25 |
| 22/12/25 |
ASX - By Stock
|
283
|
107K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
21K |
7.7M |
6 |
17/12/25 |
| 17/12/25 |
ASX - By Stock
|
21K
|
7.7M
|
6
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Study at ASH Concludes Remestemcel-L Superiority in SR-aGvHD
|
|
csrwin
|
61 |
24K |
5 |
12/12/25 |
| 12/12/25 |
ASX - By Stock
|
61
|
24K
|
5
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Study at ASH Concludes Remestemcel-L Superiority in SR-aGvHD
|
|
csrwin
|
61 |
24K |
5 |
12/12/25 |
| 12/12/25 |
ASX - By Stock
|
61
|
24K
|
5
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Study at ASH Concludes Remestemcel-L Superiority in SR-aGvHD
|
|
csrwin
|
61 |
24K |
9 |
12/12/25 |
| 12/12/25 |
ASX - By Stock
|
61
|
24K
|
9
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
csrwin
|
21K |
9.0M |
5 |
12/12/25 |
| 12/12/25 |
ASX - By Stock
|
21K
|
9.0M
|
5
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Study at ASH Concludes Remestemcel-L Superiority in SR-aGvHD
|
|
csrwin
|
61 |
24K |
10 |
12/12/25 |
| 12/12/25 |
ASX - By Stock
|
61
|
24K
|
10
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Study at ASH Concludes Remestemcel-L Superiority in SR-aGvHD
|
|
csrwin
|
61 |
24K |
12 |
12/12/25 |
| 12/12/25 |
ASX - By Stock
|
61
|
24K
|
12
|
|
|
ASX - By Stock
|
OSL |
Re:
Ann: AGM Chairman's Address and CEO & MD Presentation
|
|
csrwin
|
12 |
3.1K |
2 |
03/12/25 |
| 03/12/25 |
ASX - By Stock
|
12
|
3.1K
|
2
|
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Pursuit to Acquire High Grade Gold Project in Argentina
|
|
csrwin
|
30 |
10K |
0 |
21/11/25 |
| 21/11/25 |
ASX - By Stock
|
30
|
10K
|
0
|
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Pursuit to Acquire High Grade Gold Project in Argentina
|
|
csrwin
|
30 |
10K |
0 |
16/10/25 |
| 16/10/25 |
ASX - By Stock
|
30
|
10K
|
0
|
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Pursuit to Acquire High Grade Gold Project in Argentina
|
|
csrwin
|
30 |
10K |
2 |
09/10/25 |
| 09/10/25 |
ASX - By Stock
|
30
|
10K
|
2
|
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Pursuit to Acquire High Grade Gold Project in Argentina
|
|
csrwin
|
30 |
10K |
1 |
09/10/25 |
| 09/10/25 |
ASX - By Stock
|
30
|
10K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ Meso daily flow charts
|
|
csrwin
|
860 |
333K |
4 |
09/10/25 |
| 09/10/25 |
ASX - By Stock
|
860
|
333K
|
4
|
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
csrwin
|
3.2K |
1.3M |
5 |
08/10/25 |
| 08/10/25 |
ASX - By Stock
|
3.2K
|
1.3M
|
5
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
csrwin
|
21K |
9.0M |
33 |
08/10/25 |
| 08/10/25 |
ASX - By Stock
|
21K
|
9.0M
|
33
|
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
csrwin
|
3.2K |
1.3M |
0 |
05/10/25 |
| 05/10/25 |
ASX - By Stock
|
3.2K
|
1.3M
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
CLBP Trial 2024
|
|
csrwin
|
83 |
57K |
6 |
04/10/25 |
| 04/10/25 |
ASX - By Stock
|
83
|
57K
|
6
|
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Pursuit to Acquire High Grade Gold Project in Argentina
|
|
csrwin
|
30 |
10K |
2 |
03/10/25 |
| 03/10/25 |
ASX - By Stock
|
30
|
10K
|
2
|
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Pursuit to Acquire High Grade Gold Project in Argentina
|
|
csrwin
|
30 |
10K |
0 |
02/10/25 |
| 02/10/25 |
ASX - By Stock
|
30
|
10K
|
0
|
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Pursuit to Acquire High Grade Gold Project in Argentina
|
|
csrwin
|
30 |
10K |
1 |
01/10/25 |
| 01/10/25 |
ASX - By Stock
|
30
|
10K
|
1
|
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Pursuit to Acquire High Grade Gold Project in Argentina
|
|
csrwin
|
30 |
10K |
2 |
01/10/25 |
| 01/10/25 |
ASX - By Stock
|
30
|
10K
|
2
|
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Trading Halt
|
|
csrwin
|
8 |
2.3K |
0 |
30/09/25 |
| 30/09/25 |
ASX - By Stock
|
8
|
2.3K
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Cell Therapy Products Not Subject to U.S. Tariffs
|
|
csrwin
|
55 |
19K |
2 |
28/09/25 |
| 28/09/25 |
ASX - By Stock
|
55
|
19K
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Cell Therapy Products Not Subject to U.S. Tariffs
|
|
csrwin
|
55 |
19K |
5 |
28/09/25 |
| 28/09/25 |
ASX - By Stock
|
55
|
19K
|
5
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Cell Therapy Products Not Subject to U.S. Tariffs
|
|
csrwin
|
55 |
19K |
1 |
26/09/25 |
| 26/09/25 |
ASX - By Stock
|
55
|
19K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Cell Therapy Products Not Subject to U.S. Tariffs
|
|
csrwin
|
55 |
19K |
7 |
26/09/25 |
| 26/09/25 |
ASX - By Stock
|
55
|
19K
|
7
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
21K |
7.7M |
0 |
24/09/25 |
| 24/09/25 |
ASX - By Stock
|
21K
|
7.7M
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
21K |
7.7M |
0 |
24/09/25 |
| 24/09/25 |
ASX - By Stock
|
21K
|
7.7M
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
21K |
7.7M |
4 |
24/09/25 |
| 24/09/25 |
ASX - By Stock
|
21K
|
7.7M
|
4
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
21K |
7.7M |
1 |
24/09/25 |
| 24/09/25 |
ASX - By Stock
|
21K
|
7.7M
|
1
|
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Investor Presentation - Resource Rising Stars Gold Coast
|
|
csrwin
|
10 |
3.5K |
0 |
24/09/25 |
| 24/09/25 |
ASX - By Stock
|
10
|
3.5K
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
21K |
7.7M |
8 |
23/09/25 |
| 23/09/25 |
ASX - By Stock
|
21K
|
7.7M
|
8
|
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast 2025: The year of acting like a publicly listed company
|
|
csrwin
|
1.7K |
658K |
3 |
23/09/25 |
| 23/09/25 |
ASX - By Stock
|
1.7K
|
658K
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast 2025: The year of acting like a publicly listed company
|
|
csrwin
|
1.7K |
658K |
2 |
23/09/25 |
| 23/09/25 |
ASX - By Stock
|
1.7K
|
658K
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ceasing to be a substantial holder
|
|
csrwin
|
58 |
18K |
10 |
22/09/25 |
| 22/09/25 |
ASX - By Stock
|
58
|
18K
|
10
|
|